New cancer drug enters human testing for Tough-to-Treat tumors
NCT ID NCT07262619
Summary
This early-stage study aims to find a safe and effective dose of a new drug called EIK1005 for people with advanced solid tumors that have spread or cannot be removed by surgery. Researchers will test EIK1005 by itself and combined with an existing immunotherapy drug (pembrolizumab) in about 160 participants. The main goals are to understand the side effects and how the body processes the drug, while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Calvary Mater Newcastle Hospital
RECRUITINGWaratah, New South Wales, Australia
-
Chris O'Brien Lifehouse (Sydney Cancer Centre)
NOT_YET_RECRUITINGCamperdown, Victoria, Australia
-
GenesisCare North Shore (Oncology)
NOT_YET_RECRUITINGSaint Leonards, New South Wales, Australia
-
Grampians Health
RECRUITINGBallarat, Victoria, Australia
-
Health New Zealand
NOT_YET_RECRUITINGWellington, New Zealand
-
Memorial Sloan Kettering Cancer Center (MSKCC)
NOT_YET_RECRUITINGNew York, New York, 10022, United States
-
Morristown Medical Center
NOT_YET_RECRUITINGMorristown, New Jersey, 07960, United States
-
Oncology Clinics Victoria (OCV) - Cabrini Brighton Hospital
NOT_YET_RECRUITINGFrankston, Victoria, 3199, Australia
-
Peninsula and Southeast Oncology (PASO) Medical
RECRUITINGFrankston, Victoria, Australia
-
University of Texas MD Anderson Cancer Center
NOT_YET_RECRUITINGHouston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.